Your browser version may not work well with NCBI's Web applications. More information here...
1: Drugs Today (Barc). 2006 Jan;42(1):65-70.Click here to read Links
Republished in:
Timely Top Med Cardiovasc Dis. 2006;10:E8.

Fabry disease.

Levin M.

Department of Hematology and Oncology, University Hospital of New Jersey Medical School, Newark, New Jersey 07101, USA. mlevinmd@aol.com

Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure. Preclinical and clinical studies demonstrate effectiveness of enzyme infusion in controlling and preventing these manifestations of the disease. Copyright 2006 Prous Science

PMID: 16511611 [PubMed - indexed for MEDLINE]

Recent Activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on